Nick Turner
Professor Nick Turner is a prominent medical oncologist and lead researcher at the Institute of Cancer Research and The Royal Marsden. He has played a crucial role in the development of innovative cancer therapies, including the newly approved drug capivasertib, which has shown promising results in slowing the progression of advanced breast cancer. His research focuses on improving treatment options and outcomes for patients, emphasizing the importance of effective and kinder therapies in the management of cancer.
Not in the pool (under ¢1).
Recent news mentions
The programme features the likes of Nick Turner alongside genre-hoppers.
FNB Art Joburg returns for its 18th year, Lu Dlamini to perform at the Centre for Jazz and Popular Music and Kaleidoscope Festival returns this August – The Mail & Guardian
South Africa· 2025-08-08
Nick Turner is a professor of molecular oncology at the Institute of Cancer Research, London, and consultant medical oncologist at the Royal Marsden NHS Foundation Trust.
‘Breakthrough’ breast cancer therapy can slow advance of disease and prolong survival | Breast cancer
United Kingdom· 2025-05-31
Prof Nick Turner is the lead researcher and professor of medical oncology at the Institute of Cancer Research and The Royal Marsden.
New pill can slow progression of incurable breast cancerUnited Kingdom· 2025-04-11
